Skip to content
AwardedGermanyGoods

Studienmedikationsherstellung für klinische Prüfung MSD - PR1133410-V2-3640-I

Published
Published 6 July 2026

Overview

Fraunhofer-Gesellschaft procured the manufacture of study medication for a clinical trial (MSD PR1133410-V2-3640-I). SGS Quay Pharmaceuticals Limited was awarded the contract on 29 June 2026 for €651,275.34.

Key details

Country
Germany
Status
Awarded
Category
Goods
Procedure
Direct
Published
6 July 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€651,275
Award date
29 June 2026
Contract period
1 July 2026 → 1 December 2027
Winner
  • SGS Quay Pharmaceuticals Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    6 July 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Studienmedikationsherstellung für klinische Prüfung MSD - PR1133410-V2-3640-I — won by SGS Quay Pharmaceuticals Limited — Skim